Kaken Pharmaceutical Co Ltd

NEW
OTCPK:KKPCF (Japan)   Ordinary Shares
$ 26 (0%) 07:08 PM EST
68.23
P/B:
0.99
Market Cap:
$ 903.52M
Enterprise V:
$ 613.90M
Volume:
0
Avg Vol (2M):
0
Trade In:
Volume:
0
Avg Vol (2M):
0

Kaken Pharmaceutical Co Ltd Stock Historical Dividends and Yields

Kaken Pharmaceutical Co Ltd (KKPCF) pays a dividend yield of 0% ($380.00 per share annually). The 5-year dividend growth rate is 3.4%. Kaken Pharmaceutical Co Ltd has been paying dividends since 2014.

Below is Kaken Pharmaceutical Co Ltd's complete dividend history, ex-dividend dates, payout ratio trends, and dividend yield charts.

Dividend started since

 
2014

Years of Dividend History

 
12

Years of No Dividend Reduction

 
5

Years of Dividend Increase

 
1
0% (Trailing)
0% (Forward)

Dividend Yield

0
 

Dividend Payout Ratio

3.4%
 

Growth Rate (5-Year)

0%
 

Yield on Cost (5-Year)

-0.4%
 

3-Year Share Buyback Ratio

* Special dividend is not included in the calculation of dividend per share and related fields

Dividend Growth


Growth Rate Yield on Cost
1 Year 26.7% 0.00%
3 Year 8.2% 0.00%
5 Year 3.4% 0%
10 Year 1.5% 0.00%

Kaken Pharmaceutical Co Ltd Dividend History & Ex-Dividend Dates

Complete history of 26 dividend payments by Kaken Pharmaceutical Co Ltd since 2014. Each row shows the ex-dividend date, amount per share, record date, pay date, and declaration date.

Kaken Pharmaceutical Co Ltd (KKPCF) Dividend History
Ex-Dividend Date Amount Record Date Pay Date Declaration Date
2027-03-31 JPY 95 2027-03-31 0000-00-00 2026-05-13
2026-09-30 JPY 95 2026-09-30 0000-00-00 2026-05-13
2026-03-31 JPY 95 2026-03-31 2026-06-29 2025-05-12
2025-09-29 JPY 95 2025-09-30 2025-11-28 2025-05-12
2025-03-28 JPY 75 2025-03-31 2025-06-30 2024-05-14
2024-09-27 JPY 40 2024-09-30 2024-11-29 2024-08-07
2024-09-27 JPY 75 2024-09-30 2024-11-29 2024-05-14
2024-03-28 JPY 75 2024-03-31 2024-06-28 2023-05-10
2023-09-28 JPY 75 2023-09-30 2023-11-30 2023-05-10
2023-03-30 JPY 75 2023-03-31 2023-06-30 2022-05-11
2022-09-29 JPY 75 2022-09-30 2022-11-30 2022-05-11
2022-03-30 JPY 75 2022-03-31 2022-06-30 2021-05-07
2021-09-29 JPY 75 2021-09-30 2021-11-30 2021-05-07
2020-09-29 JPY 75 2020-09-30 2020-11-30 2020-05-22
2020-03-30 JPY 75 2020-03-31 2020-06-29 2019-05-09
2019-09-27 JPY 75 2019-09-30 0000-00-00 2019-05-09
2019-03-27 JPY 75 2019-03-31 2019-06-28 2018-05-09
2018-09-28 JPY 75 2018-09-30 2018-11-30 2018-09-08
2018-03-28 JPY 75 2018-03-31 2018-06-29 2017-05-10
2017-09-27 JPY 75 2017-09-30 2017-11-30 2017-09-07
2017-03-29 JPY 75 2017-03-31 2017-06-30 2017-03-09
2016-09-28 JPY 75 2016-09-30 0000-00-00 2016-06-14
2016-03-28 JPY 68 2016-03-31 0000-00-00 2016-03-08
2015-09-28 JPY 68 2015-09-30 2015-11-30 2015-05-13
2015-03-27 JPY 64 2015-03-31 2015-06-29 2015-03-07
2014-09-26 JPY 54 2014-09-30 2014-11-28 2014-09-06

Frequently Asked Questions: KKPCF Dividend

Does Kaken Pharmaceutical Co Ltd (KKPCF) pay a dividend?

Kaken Pharmaceutical Co Ltd (KKPCF) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Kaken Pharmaceutical Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Kaken Pharmaceutical Co Ltd has returned capital to shareholders via buybacks at a rate of -0.4% over the past 3 years.

What are dividend-paying alternatives to Kaken Pharmaceutical Co Ltd?

For dividend-paying alternatives in Kaken Pharmaceutical Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.

Dividend Yield History

Good Dividend Yield % : Close to 10-year high
This is the historical trailing annual dividend yield of Kaken Pharmaceutical Co Ltd. Buying stocks at higher yield relative its historical values is usually more profitable.

Dividend Per Share History

This the dividend history of Kaken Pharmaceutical Co Ltd

Dividend Payout Ratio

This is the historical payout ratio of Kaken Pharmaceutical Co Ltd. If the dividend payout ratio is close to or higher than 1, dividends might not be sustainable.